Navigation Links
Soligenix Executes Exclusive License with the University of Colorado for Vaccine Thermostabilization Technology
Date:1/27/2011

rategies for their use, especially in public health emergencies or in developing countries.  We are pleased that Soligenix has licensed our technology, which offers the potential to create vaccine formulations whose enhanced thermostability allows them to be stockpiled and delivered to patients with much less stringent temperature control requirements."

"The achievement of extended stability as well as stability under elevated temperature would represent a significant step forward in vaccine technology. These properties are not shared with conventional vaccines that require refrigeration," stated Robert N. Brey, PhD, Chief Scientific Officer of Soligenix. "Lack of long-term stability is a significant problem in vaccines for use in emergency situations and especially for vaccines used in the developing world where the cold storage chain is difficult to maintain.  Further, this novel thermostability technology has the potential to allow us to expand our vaccine business into the development of countermeasures against other more common infectious diseases."

About Soligenix, Inc.

Soligenix, Inc. (Soligenix) is a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. Through its Biodefense Division, Soligenix is developing biomedical countermeasures pursuant to the Project BioShield Act of 2004. Soligenix's lead biodefense product in development is a recombinant subunit vaccine called RiVax™, which is designed to protect against the lethal effects of exposure to ricin toxin. RiVax™ has been shown to be well tolerated and immunogenic in a Phase 1 clinical trial in normal volunteers. RiVax™ is also the subject of a $9.4 million NIAID grant received by the Company supporting development of new heat stable vaccines.

Soligenix's lead product, orBec® (oral beclometh
'/>"/>

SOURCE Soligenix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Soligenix Announces Positive Preliminary Results of SGX202 in Radiation Injury
2. Soligenix Announces Preliminary Results of its Phase 2 Clinical Trial of orBec® in the Prevention of Acute GVHD
3. Soligenix to Present at the Rodman & Renshaw Healthcare Conference on September 15, 2010 at 10AM EDT
4. Soligenix Announces Award of $1.2 Million FDA Orphan Products Development Grant
5. Soligenix to Present at the OneMedForum Conference on Wednesday, June 30 at 2PM EDT
6. Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration
7. Soligenix Announces Issuance of Hong Kong Patent for its LPM(TM) Oral Drug Delivery Technology
8. Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin
9. Soligenix Announces Publication of Positive Pre-Clinical Results with RiVax(TM), Its Vaccine Against Ricin Toxin
10. Soligenix Announces Initiation of a Phase 1/2 Clinical Trial of SGX201 for the Prevention of Acute Radiation Enteritis
11. Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... 1, 2015 ExeGi Pharma, a company focused ... announced today that it has been granted a product ... Products Directorate (NNHPD) to sell Visbiome™ in ... by Professor Claudio De Simone , MD, PhD ... Professor De Simone recently signed an exclusive agreement with ...
(Date:7/1/2015)... 2015 According to a new ... Method (Biochemical (Calcium Phosphate, Lipofection, Dendrimers), Physical (Electroporation, Nucleofection), ... Global Forecast to 2020", published by MarketsandMarkets, the Transfection ... $957.9 Million by 2020 with a CAGR of 7.2% ... market T ables and 33 F ...
(Date:7/1/2015)... Mass. , July 1, 2015 Boston Scientific ... discussing financial results and business highlights for the second quarter ... 8 a.m. ET. The call will be hosted ... and Dan Brennan , executive vice president and chief ... call will be available via the Boston Scientific website. Webcast ...
Breaking Medicine Technology:ExeGi Pharma Secures Canadian Approval For Well Studied Probiotic 2ExeGi Pharma Secures Canadian Approval For Well Studied Probiotic 3Transfection Reagents and Equipment Market Worth $957.9 Million by 2020 2Transfection Reagents and Equipment Market Worth $957.9 Million by 2020 3Transfection Reagents and Equipment Market Worth $957.9 Million by 2020 4Boston Scientific To Webcast Second Quarter 2015 Earnings Call On July 23 2
(Date:7/1/2015)... ... 2015 , ... There is nothing new about marriage debates ... laws governing sexuality since the first Pilgrims landed at Plymouth Rock. The mid-1870s, ... Cindy Safronoff reveals. Crossing Swords: Mary Baker Eddy vs. Victoria Claflin Woodhull and ...
(Date:7/1/2015)... Lewisberry, PA (PRWEB) , ... July 01, 2015 ... ... their purist natural forms, such as organically raised chickens and eggs. Eating organic ... Raising backyard chickens is cleaner and more environmentally friendly than production chicken farming. ...
(Date:7/1/2015)... ... ... Renowned rhinoplasty surgeon and Symposium Chairman, Dr. Rod J. ... Set for March 6th - 8th, the 2016 meeting will be held at the ... fundamentals of nasal surgery through the most modern advancements and updates in rhinoplasty and ...
(Date:7/1/2015)... ... ... Did you know that infertility in men is more common than couples ... Center of Texas (AFCT) would like to talk about some natural ways to increase ... be a “woman’s issue,” male fertility factors can play a role in about 40% ...
(Date:7/1/2015)... ... , ... Convoy of Hope will partner with local businesses, churches, ... August 1, at Spring Lake Park High School. , During the celebration, Convoy of ... of goods and services including free food, health services, family portraits, job services, a ...
Breaking Medicine News(10 mins):Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 2Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 3Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 4Health News:Chicken Coop Condo Offer New Chicken Coop Designs 2Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 2Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 3Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 4Health News:Convoy of Hope Hosts Community Event in the Twin Cities 2
... Trial of 16 patients saw 46% improvement in symptoms ... drug -- oral EN101antisense -- reduced the severity of ... , Myasthenia gravis (MG), which affects about 20 in ... muscles. Other symptoms may include double vision, drooping eyelids, ...
... a much greater risk of finger and toe deformities, , , FRIDAY, ... new parent does is count the baby,s fingers and toes. ... unhappy surprise, because smoking increases the odds that a baby will ... half a pack a day increased the risk of having a ...
... is accumulating on how bad stress is for ... a persons risk for developing central nervous system ... other inflammatory diseases, say researchers presenting at the ... (APA). These researchers have demonstrated for the first ...
... people now diagnosed as having depression? Two experts give their ... psychiatrist from Australia says the current threshold for what is ... fears it could lead to a diagnosis of depression becoming ... be depressed and points to his own cohort study which ...
... with chronic myeloid leukemia (CML) are treated first with ... protein known to cause the cancer (BCR-ABL). If their ... to the effects of imatinib, individuals are treated with ... in a different way. However, patients that relapse after ...
... 16, 2007 One in three people exposed to ... symptoms that may require treatment, according to research published ... American Dental Association. , Researchers at Ume University, Sweden, ... dysfunction in 60 patients in hospital emergency rooms directly ...
Cached Medicine News:Health News:Another Reason Not to Smoke While Pregnant: Birth Defects 2Health News:Another Reason Not to Smoke While Pregnant: Birth Defects 3Health News:New research shows how chronic stress worsens neurodegenerative disease course 2Health News:New research shows how chronic stress worsens neurodegenerative disease course 3Health News:Are too many people diagnosed as 'depressed?' 2
... operate with either one, eight, or twelve ... an imaging process to map the entire ... individual signals can overlap). The reader from ... containing 96 parallel micro-objectives. The 96 individual ...
... combine excellent specifications and performance with convenience ... powerful performance at a price much lower ... line includes several models with options that ... OEM users, including the ability to read ...
The DELFIA Platewash is a general purpose microtitration plate and strip washer especially standardized for use with DELFIA diagnostic kits....
Easy to use , Allow for a flexible washing , Uniform and efficient , Very robust and reliable , Adjustable to all well shapes , Rack included (not autoclavable) , Autoclavable at 121C , No e...
Medicine Products: